The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
USR Unitat Transversal de Recerca
USR Unitat Transversal de Recerca
Presentation
Team
Groups
Publications
Projects
News
Presentation
Team
Groups
Publications
Projects
News
Projects
Group projects
Ranitidine and other histamine-H2-receptor antagonists – Drug Utilisation Study
Principal investigators:
Talita Duarte Salles
Code:
4R19/100
Start year:
2019
Funders:
European Medicines Agency (EMA)
Cohorte DESVELA. Análisis del papel de las aptitudes personales como DEterminantes de la incidencia de morbilidad, eStilos de vida, calidad de Vida, uso de sErvicios y mortaLidAd
Principal investigators:
Bonaventura Bolíbar Ribas, Diana Puente Baliarda
Code:
4R19/112
Start year:
2019
Funders:
Instituto de Salud Carlos III
Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: a SIDIAP-OHDSI based cohort study
Principal investigators:
Talita Duarte Salles
Code:
4R20/044
Start year:
2020
Funders:
University of Oxford
OHDSI: Comparative risk of the incident cancer between histamine-2 receptor antagonists
Principal investigators:
Talita Duarte Salles
Code:
4R20/048
Start year:
2020
Funders:
Kandong Sacred Heart Hospital
Use of hydrochlorothiazide and risk of skin cancer
Principal investigators:
Talita Duarte Salles
Code:
4R20/082
Start year:
2020
Funders:
Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)
Anterior
1
…
6
7
8
9
10
…
78
Següent
Board of Trustees
Collaborators
Accreditations